Hims & Hers Health (HIMS) Cash from Investing Activities Growth (1y) (2020 - 2026)
Hims & Hers Health (HIMS) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Hims & Hers Health | 7.81 Bn | 6.97 Bn | 480.80 Mn | 500.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 500.88% |
| Mar 31, 2026 | 52.90% |
| Dec 31, 2025 | -386.32% |
| Sep 30, 2025 | -8,421.20% |
| Jun 30, 2025 | -371.77% |
| Mar 31, 2025 | -351.46% |
| Dec 31, 2024 | -183.14% |
| Sep 30, 2024 | 66.47% |
| Jun 30, 2024 | -288.37% |
| Mar 31, 2024 | 417.09% |
| Dec 31, 2023 | 244.74% |
| Sep 30, 2023 | -1,105.78% |
| Jun 30, 2023 | -81.49% |
| Mar 31, 2023 | -122.29% |
| Dec 31, 2022 | -41.39% |
| Sep 30, 2022 | 90.06% |
| Jun 30, 2022 | -43.62% |
| Mar 31, 2022 | 111.30% |
| Dec 31, 2021 | 226.73% |
| Sep 30, 2021 | -4.74% |